Cargando…

Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists

AIM: To evaluate personnel involved in scarce drug prioritization and distribution and the criteria used to inform drug distribution during times of shortage among pediatric hematologists/oncologists. METHODS: Using the American Society of Pediatric Hematology/Oncology (ASPHO) membership list, a 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Beck, Jill C, Chen, Baojiang, Gordon, Bruce G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554877/
https://www.ncbi.nlm.nih.gov/pubmed/28848700
http://dx.doi.org/10.5306/wjco.v8.i4.336
_version_ 1783256853696741376
author Beck, Jill C
Chen, Baojiang
Gordon, Bruce G
author_facet Beck, Jill C
Chen, Baojiang
Gordon, Bruce G
author_sort Beck, Jill C
collection PubMed
description AIM: To evaluate personnel involved in scarce drug prioritization and distribution and the criteria used to inform drug distribution during times of shortage among pediatric hematologists/oncologists. METHODS: Using the American Society of Pediatric Hematology/Oncology (ASPHO) membership list, a 20 question survey of pediatric hematologists/oncologists was conducted via email to evaluate personnel involved in scarce drug prioritization and distribution and criteria used to inform scarce drug distribution. RESULTS: Nearly 65% of the 191 study respondents had patients directly affected by drug shortages. Most physicians find out about shortages from the pharmacist (n = 179, 98%) or other doctors (n = 75, 41%). One third of respondents do not know if there is a program or policy for handling drug shortages at their institution. The pharmacist was the most commonly cited decision maker for shortage drug distribution (n = 128, 70%), followed by physicians (n = 109, 60%). One fourth of respondents did not know who makes decisions about shortage drug distribution at their institution. The highest priority criterion among respondents was use of the shortage drug for curative, rather than palliative intent and lowest priority criterion was order of arrival or first-come first-served. CONCLUSION: Despite pediatric hematology/oncology physicians and patients being heavily impacted by drug shortages, institutional processes for handling shortages are lacking. There is significant disparity between how decisions for distribution of shortage drugs are currently made and how study respondents felt those decisions should be made. An institution-based, and more importantly, a societal approach to drug shortages is necessary to reconcile these disparities.
format Online
Article
Text
id pubmed-5554877
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-55548772017-08-28 Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists Beck, Jill C Chen, Baojiang Gordon, Bruce G World J Clin Oncol Retrospective Study AIM: To evaluate personnel involved in scarce drug prioritization and distribution and the criteria used to inform drug distribution during times of shortage among pediatric hematologists/oncologists. METHODS: Using the American Society of Pediatric Hematology/Oncology (ASPHO) membership list, a 20 question survey of pediatric hematologists/oncologists was conducted via email to evaluate personnel involved in scarce drug prioritization and distribution and criteria used to inform scarce drug distribution. RESULTS: Nearly 65% of the 191 study respondents had patients directly affected by drug shortages. Most physicians find out about shortages from the pharmacist (n = 179, 98%) or other doctors (n = 75, 41%). One third of respondents do not know if there is a program or policy for handling drug shortages at their institution. The pharmacist was the most commonly cited decision maker for shortage drug distribution (n = 128, 70%), followed by physicians (n = 109, 60%). One fourth of respondents did not know who makes decisions about shortage drug distribution at their institution. The highest priority criterion among respondents was use of the shortage drug for curative, rather than palliative intent and lowest priority criterion was order of arrival or first-come first-served. CONCLUSION: Despite pediatric hematology/oncology physicians and patients being heavily impacted by drug shortages, institutional processes for handling shortages are lacking. There is significant disparity between how decisions for distribution of shortage drugs are currently made and how study respondents felt those decisions should be made. An institution-based, and more importantly, a societal approach to drug shortages is necessary to reconcile these disparities. Baishideng Publishing Group Inc 2017-08-10 2017-08-10 /pmc/articles/PMC5554877/ /pubmed/28848700 http://dx.doi.org/10.5306/wjco.v8.i4.336 Text en ©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Retrospective Study
Beck, Jill C
Chen, Baojiang
Gordon, Bruce G
Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title_full Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title_fullStr Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title_full_unstemmed Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title_short Physician approaches to drug shortages: Results of a national survey of pediatric hematologist/oncologists
title_sort physician approaches to drug shortages: results of a national survey of pediatric hematologist/oncologists
topic Retrospective Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554877/
https://www.ncbi.nlm.nih.gov/pubmed/28848700
http://dx.doi.org/10.5306/wjco.v8.i4.336
work_keys_str_mv AT beckjillc physicianapproachestodrugshortagesresultsofanationalsurveyofpediatrichematologistoncologists
AT chenbaojiang physicianapproachestodrugshortagesresultsofanationalsurveyofpediatrichematologistoncologists
AT gordonbruceg physicianapproachestodrugshortagesresultsofanationalsurveyofpediatrichematologistoncologists